ANGPTL3 and familial hypercholesterolemia: Based on data emerging from various GWA studies on ANGPTL3 and its role in regulating plasma lipid levels, ANGPTL3 has been targeted as a treatment for people with elevated plasma lipids, especially for people diagnosed with homozygous familial hypercholesterolemia.